Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01785784Phase 4Completed
A Phase 4 trial of rhGM-CSF gel in deep partial-thickness burn, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01785784.